Spencer Feldman

This guide explains diagnosis, staging, molecular testing and treatment options for non-small cell lung cancer to help patients prepare informed questions.

Triple-negative breast cancer often needs chemotherapy, surgery, radiation or immunotherapy, and early diagnosis can support strong outcomes.

In this Q&A, Emma and Paul share how self-advocacy and communication shaped their experience with hepatocellular carcinoma after an unexpected diagnosis.

An expert explains how minimally invasive surgery helps remove smaller lung areas with quicker recovery and improves outcomes for patients with early-stage lung cancer.

Dr. Charles M. Rudin highlights T cell engagers, antibody-drug conjugates and emerging strategies showing early benefits for small cell lung cancer.

Sac-TMT plus Keytruda improved time without cancer growth in people with advanced lung cancer whose tumors show programmed death ligand 1.

Early data indicate Voranigo is rapidly being used in newly diagnosed and previously treated patients with IDH-mutant glioma, highlighting ongoing treatment needs.

Keytruda and Padcev improve event-free and overall survival for adults with muscle invasive bladder cancer who cannot receive cisplatin after surgery.

Giredestrant improved invasive disease-free survival for people with estrogen receptor-positive early breast cancer compared with standard treatment.

The FDA approved Imdelltra after a study showed longer survival compared with chemotherapy in advanced small cell lung cancer.

The oral therapy DPTX3186 received fast track status to help speed development of a potential new option for patients with gastric cancer.

This guide explains diagnosis, staging, treatment options, side effects and a patient’s metastatic experience with osteosarcoma.

A study at IKCS finds higher BMI after kidney cancer diagnosis improves survival, while significant weight loss predicts poorer outcomes.

FOG-001 received fast track designation after early study results showed tumor shrinkage in all evaluable patients with desmoid tumors.

Cindy and Katie share how caring for parents with cholangiocarcinoma led to friendship, support and advocacy through the Cholangiocarcinoma Foundation.

Trial data showed a 62% complete response rate at 6 months with detalimogene coraplasmid among patients with high-risk, BCG-unresponsive bladder cancer.

Dr. Minetta Liu explains how Signatera detects tumor DNA after bladder surgery, guiding treatment and identifying patients who need immunotherapy.

MB-105 received a special FDA status to help deliver faster treatment options for people with relapsed T-cell lymphoma who have few options.

Dave Nitsche, a nonsmoker and endurance athlete, pushes back against stigma and stays active while advocating for lung cancer screening.

Thymoma is a rare cancer of the thymus that can be treated with surgery, radiation, chemotherapy or immunotherapy depending on stage.

Kimberly Alexander urges care partners to seek support, prioritize self-care and push for better awareness so families in the Black community aren’t overlooked.

Long-awaited progress in rectal and gastric cancer research includes a fast track designation and new survival data.

Learn how HR-positive/HER2-negative breast cancer is diagnosed, treated by stage and managed for side effects to guide patient-oncologist discussions.

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay chemotherapy and radiation.

Stoboclo and Osenvelt is now interchangeable with brand-name drugs, per the FDA, letting pharmacists substitute them while ensuring safety and efficacy.

Tamron Little was diagnosed with peritoneal mesothelioma after childbirth and now, 18 years later, she says survivorship is lifelong.

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as survivorship becomes a key focus.

Therapies may affect ovarian function and cause early menopause, and many younger women can still pursue family planning with guidance from their care team.

Twanda Frazier guides patients with cancer through Reiki, helping them release stress and find calm, while survivor Radha Narayan shares her positive experience.

Dr Anjana Pillai explains screening, imaging and biopsy for liver cancer, why staging matters and which questions help patients understand care.